Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD)

Clinical trial NCT04094402 · UNKNOWN

Trial details

NCT number: NCT04094402
Sponsor: Scandinavia Pharma
Status: UNKNOWN
Study type: OBSERVATIONAL

Gastroesophageal Reflux Disease

Start date: 2019-06-04
Primary completion: 2023-12-01
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.